Loni Jay, MD
Family Practice · Folsom
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 6
Offices
6 locations · Sutter Valley Medical Foundation · Sutter Bay Medical Foundation · Marshall Medical Center
Hospitals listed: Sutter Roseville Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Jay’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A132204 · Current
Licensed to practise in California · since 2014 · expires 2027-11-30 · University of Utah School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Sutter Roseville Medical CenterRoseville, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Pressure ulcer rate: 0.08 (0 to 0.56) · 12,400 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.069, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.262, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.128, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.357, Oct 2024 – Sep 2025
See every measure and the patient survey for Sutter Roseville Medical Center
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 5 better, 1 the same, 1 worse of 7 measures. Readmissions: 2 better, 7 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Pressure ulcer rateComplications and deaths | 0.08 (0 to 0.56) · 12,400 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.069 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.262 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.128 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.357 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.33 (0.49 to 2.17) · 2,916 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.63 to 1.17) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 147.2 (107.33 to 187.07) · 191 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 250 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.7 · 484 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 839 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.3 · 1,027 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10 · 656 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 6,822 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.08 to 0.42) · 14,300 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.06 to 0.41) · 14,490 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.43 (2.77 to 6.08) · 3,117 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.38 (0 to 2.95) · 938 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.06 (0.76 to 3.36) · 2,944 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.03 (2.8 to 15.25) · 840 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.43 (3.11 to 9.75) · 899 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.34 to 3.11) · 819 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.4 · 35 cases | None | Apr 2023 – Mar 2025 |
| SSI - Colon SurgeryInfections | 0.41 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 527 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 1,094 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -16.6 · 443 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -11 · 961 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -8 · 1,064 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 1,293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.5 to 8.7) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (6.9 to 14.9) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.5 · 310 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.8 to 17.9) · 116 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 1,600 cases | No different | Jan 2024 – Dec 2024 |
What patients said (537 patients answered, 24% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$34,234
Medicare paid this office $34,234 for 264 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 233 | $24,252 | $94 |
| Long return visit (40+ min) | 22 | $3,472 | $145 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 16 | $2,236 | $140 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 17 | $905 | $50 |
| Short return visit (20+ min) | 11 | $765 | $70 |
See all 8 services
| Return visit (30+ min) | 233 | $24,252 | $94 |
| Long return visit (40+ min) | 22 | $3,472 | $145 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 16 | $2,236 | $140 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 17 | $905 | $50 |
| Short return visit (20+ min) | 11 | $765 | $70 |
| Injection of drug or substance under skin or into muscle | 15 | $196 | $12 |
| Automated urinalysis test | 46 | $106 | $2 |
| Injection, ceftriaxone sodium, per 250 mg | 11 | $16 | None |
Procedures Medicare counted
| Removal of nail tissue | 1-10 | None |
Who their Medicare patients are
264 Original Medicare patients in 2024. Average age 75 · Under 65 4% · 85 and older 14% · Women 62% · Also on Medicaid 6% · Health risk score 1.06. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 69% · Coronary heart disease 27% · Diabetes 23% · Depression 22% · Cancer 21% · Chronic kidney disease 20% · COPD 19% · Atrial fibrillation 19% · Heart failure 15% · Stroke 8% · Dementia 7%.
The office billed $125,443, Medicare allowed $46,525 and paid $34,234; for 578 services of 34 kinds; $32 of it was for drugs given in the office and $34,202 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 264 | 578 | 75 | 1.06 | $125,443 | $34,234 |
| 2023 | 172 | 344 | 74 | 1.25 | $88,003 | $24,768 |
| 2022 | 227 | 708 | 75 | 1.14 | $144,170 | $43,661 |
| 2021 | 170 | 641 | 73 | 1.04 | $175,637 | $54,279 |
| 2020 | 92 | 671 | 61 | 1.95 | $91,291 | $41,038 |
| 2019 | 102 | 545 | 64 | 1.70 | $101,101 | $42,144 |
| 2018 | 249 | 884 | 72 | 1.53 | $97,538 | $54,135 |
| 2017 | 240 | 1,027 | 72 | 1.26 | $101,258 | $58,141 |
| 2016 | 119 | 260 | 73 | 1.17 | $22,967 | $15,605 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 141 | $14,618 | $89 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 18 | $2,437 | $135 |
| Advance care planning, first 30 minutes | 13 | $988 | $76 |
| Short return visit (20+ min) | 17 | $889 | $52 |
| Automated urinalysis test | 12 | $26 | $2 |
2022: 8 services
| Return visit (30+ min) | 151 | $19,731 | $91 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 50 | $6,898 | $138 |
| Long return visit (40+ min) | 20 | $3,005 | $143 |
| Short return visit (20+ min) | 41 | $2,614 | $59 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 20 | $1,405 | $70 |
| Advance care planning, first 30 minutes | 12 | $1,010 | $84 |
| Administration of influenza virus vaccine | 22 | $689 | $31 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 12 | $120 | $10 |
2021: 12 services
| Return visit (30+ min) | 115 | $23,383 | $103 |
| New patient visit (45+ min) | 63 | $6,857 | $109 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 41 | $5,739 | $140 |
| Short return visit (20+ min) | 47 | $4,023 | $73 |
| Long return visit (40+ min) | 15 | $2,293 | $135 |
| Pneumococcal vaccine, 23-valent | 17 | $2,129 | $125 |
| Influenza vaccine split virus, preservative free | 28 | $1,823 | $65 |
| Administration of influenza virus vaccine | 29 | $525 | $18 |
| Administration of pneumococcal vaccine | 17 | $308 | $18 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 11 | $126 | $10 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $38 | None |
| Automated urinalysis test | 12 | $32 | $2 |
2020: 6 services
| Return visit (30+ min) | 80 | $22,603 | $82 |
| Telephone medical discussion with physician, 21-30 minutes | 62 | $12,274 | $76 |
| Short return visit (20+ min) | 12 | $1,913 | $56 |
| Testing for presence of drug, read by direct observation | 40 | $1,361 | $12 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $816 | $54 |
| Injection of drug or substance under skin or into muscle | 17 | $450 | $10 |
2019: 5 services
| Return visit (30+ min) | 84 | $29,576 | $89 |
| Short return visit (20+ min) | 37 | $5,719 | $60 |
| Long return visit (40+ min) | 22 | $2,798 | $122 |
| New patient visit (45+ min) | 17 | $1,913 | $113 |
| Testing for presence of drug, read by direct observation | 33 | $655 | $12 |
2018: 7 services
| Return visit (30+ min) | 192 | $30,868 | $59 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 32 | $5,709 | $178 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 41 | $4,992 | $122 |
| Short return visit (20+ min) | 79 | $3,027 | $34 |
| Long return visit (40+ min) | 17 | $2,007 | $96 |
| Destruction of precancer skin growth, 1 growth | 13 | $579 | $36 |
| Short return visit | 13 | $155 | $12 |
2017: 14 services
| Return visit (30+ min) | 180 | $27,632 | $56 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 53 | $9,359 | $177 |
| Short return visit (20+ min) | 101 | $5,140 | $37 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 22 | $2,640 | $120 |
| Transitional care management services for problem of high complexity | 12 | $1,951 | $130 |
| New patient visit (45+ min) | 24 | $1,644 | $68 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 11 | $1,424 | $129 |
| Advance care planning, first 30 minutes | 20 | $1,185 | $59 |
| Destruction of precancer skin growth, 1 growth | 21 | $1,060 | $39 |
| Long return visit (40+ min) | 11 | $955 | $73 |
| Transitional care management services for problem of at least moderate complexity | 11 | $898 | $82 |
| Short return visit | 27 | $556 | $20 |
| Destruction of precancer skin growth, 2-14 growths | 15 | $143 | $2 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 21 | $114 | $5 |
2016: 4 services
| Return visit (30+ min) | 77 | $8,571 | $63 |
| New patient visit (45+ min) | 23 | $2,313 | $101 |
| New patient visit (30+ min) | 14 | $762 | $54 |
| Short return visit (20+ min) | 16 | $663 | $41 |
Medicaid work
$133,764 in 2020
Medicaid paid $133,764 for 3,618 billed services this clinician did in 2020, up to 153 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 1,630 | $86,365 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 594 | $13,362 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; capable of being read by direct optical observation only (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of service | 870 | $13,279 |
| Short return visit (20+ min) | 356 | $13,246 |
| New patient visit (45+ min) | 41 | $4,637 |
| Smoking and tobacco use cessation counseling visit; intensive, greater than 10 minutes | 106 | $2,628 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 21 | $246 |
| 2020 | 3,618 | 7 | 153 | $133,764 |
| 2019 | 1,726 | 5 | 88 | $67,130 |
| 2018 | 635 | 5 | 38 | $36,100 |
See the largest Medicaid services in earlier years
2019
| Return visit (30+ min) | 923 | $45,939 |
| Short return visit (20+ min) | 355 | $11,908 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; capable of being read by direct optical observation only (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of service | 387 | $6,214 |
| New patient visit (45+ min) | 26 | $2,336 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 35 | $734 |
2018
| Return visit (30+ min) | 396 | $19,042 |
| Clinic visit/encounter, all-inclusive | 109 | $15,960 |
| Short return visit (20+ min) | 33 | $871 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; capable of being read by direct optical observation only (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of service | 19 | $227 |
| Hospital outpatient clinic visit for assessment and management of a patient | 78 | $0 |
Drugs they prescribed that Part D paid
$3,051
Pharmacies billed $3,051 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
336 generic and fewer than 11 brand-name prescriptions · $3,051 in drug cost · 184 antibiotic prescriptions to 155 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Amoxicillin-Clavulanate Potass | 34 | $279 | $8 |
| Cephalexin | 43 | $222 | $5 |
| Doxycycline Hyclate | 16 | $127 | $8 |
| Nitrofurantoin Mono-Macro | 12 | $124 | $10 |
| Azithromycin | 31 | $120 | $4 |
See all 8 drugs
| Amoxicillin-Clavulanate Potass | 34 | $279 | $8 |
| Cephalexin | 43 | $222 | $5 |
| Doxycycline Hyclate | 16 | $127 | $8 |
| Nitrofurantoin Mono-Macro | 12 | $124 | $10 |
| Azithromycin | 31 | $120 | $4 |
| Prednisone | 38 | $106 | $3 |
| Sulfamethoxazole-Trimethoprim | 15 | $53 | $4 |
| Paxlovid | 14 | $0 | $0 |
Year by year
| 2024 | 364 | 246 | None | None | $3,051 |
| 2023 | 1,026 | 232 | 7% (76) | None | $86,291 |
| 2022 | 1,999 | 305 | 9% (175) | 12% | $195,611 |
| 2021 | 1,437 | 204 | 10% (139) | 15% | $169,724 |
| 2020 | 1,644 | 115 | 19% (315) | None | $389,062 |
| 2019 | 1,553 | 150 | 20% (309) | 26% | $227,691 |
| 2018 | 2,275 | 251 | 10% (235) | 20% | $224,494 |
| 2017 | 1,767 | 235 | 5% (79) | 16% | $198,909 |
| 2016 | 883 | 144 | 8% (68) | None | $50,976 |
| 2015 | 423 | 77 | 14% (61) | None | $22,596 |
| 2014 | 60 | 30 | None | None | $1,976 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 28 drugs
| Trulicity | 12 | $16,516 | $1,376 |
| Eliquis | 13 | $7,679 | $591 |
| Buprenorphine | 13 | $4,326 | $333 |
| Atorvastatin | 59 | $714 | $12 |
| Levothyroxine | 45 | $666 | $15 |
| Albuterol Sulfate Hfa | 23 | $648 | $28 |
| Losartan | 36 | $484 | $13 |
| Losartan-Hydrochlorothiazide | 17 | $335 | $20 |
| Diltiazem 24hr Er (Cd) | 11 | $328 | $30 |
| Tamsulosin | 15 | $327 | $22 |
| Rosuvastatin | 25 | $325 | $13 |
| Gabapentin | 33 | $324 | $10 |
| Bupropion Xl | 20 | $321 | $16 |
| Famotidine | 15 | $276 | $18 |
| Hydrocodone-Acetaminophen | 18 | $271 | $15 |
| Trazodone | 12 | $235 | $20 |
| Paroxetine | 12 | $210 | $17 |
| Hydrochlorothiazide | 34 | $201 | $6 |
| Amoxicillin-Clavulanate Potass | 17 | $192 | $11 |
| Lisinopril | 29 | $162 | $6 |
| Levetiracetam | 11 | $150 | $14 |
| Doxycycline Hyclate | 11 | $146 | $13 |
| Omeprazole | 13 | $124 | $10 |
| Amlodipine Besylate | 11 | $98 | $9 |
| Alendronate | 13 | $75 | $6 |
| Tramadol | 15 | $72 | $5 |
| Folic Acid | 14 | $58 | $4 |
| Prednisone | 15 | $54 | $4 |
2022: 53 drugs
| Trulicity | 24 | $36,460 | $1,519 |
| Symbicort | 17 | $14,175 | $834 |
| Eliquis | 17 | $10,624 | $625 |
| Buprenorphine | 29 | $9,010 | $311 |
| Jardiance | 12 | $7,322 | $610 |
| Sumatriptan | 12 | $7,121 | $593 |
| Albuterol Sulfate Hfa | 42 | $2,120 | $50 |
| Gabapentin | 69 | $1,840 | $27 |
| Atorvastatin | 101 | $1,560 | $15 |
| Oxycodone | 23 | $1,033 | $45 |
| Hydrocodone-Acetaminophen | 49 | $911 | $19 |
| Levothyroxine | 51 | $819 | $16 |
| Lisinopril | 70 | $737 | $11 |
| Famotidine | 35 | $709 | $20 |
| Rosuvastatin | 21 | $686 | $33 |
| Tamsulosin | 34 | $607 | $18 |
| Quetiapine | 15 | $600 | $40 |
| Duloxetine | 27 | $583 | $22 |
| Losartan | 63 | $552 | $9 |
| Trazodone | 25 | $530 | $21 |
| Omeprazole | 29 | $509 | $18 |
| Eplerenone | 11 | $444 | $40 |
| Pravastatin | 24 | $404 | $17 |
| Bupropion Hcl Sr | 11 | $398 | $36 |
| Carvedilol | 24 | $379 | $16 |
| Tramadol | 41 | $373 | $9 |
| Allopurinol | 23 | $372 | $16 |
| Fluticasone Propionate | 15 | $366 | $24 |
| Paroxetine | 15 | $350 | $23 |
| Metoprolol | 19 | $294 | $15 |
| Losartan-Hydrochlorothiazide | 21 | $276 | $13 |
| Warfarin | 12 | $274 | $23 |
| Montelukast | 22 | $267 | $12 |
| Triamterene-Hydrochlorothiazid | 13 | $266 | $20 |
| Alendronate | 15 | $258 | $17 |
| Simvastatin | 22 | $251 | $11 |
| Zolpidem | 31 | $250 | $8 |
| Nebivolol | 12 | $249 | $21 |
| Amlodipine Besylate | 31 | $249 | $8 |
| Furosemide | 25 | $208 | $8 |
| Fluconazole | 24 | $207 | $9 |
| Lorazepam | 27 | $197 | $7 |
| Hydrochlorothiazide | 48 | $186 | $4 |
| Metformin | 28 | $175 | $6 |
| Pantoprazole | 12 | $168 | $14 |
| Sertraline | 33 | $150 | $5 |
| Metformin Hcl Er | 17 | $139 | $8 |
| Baclofen | 11 | $117 | $11 |
| Metoprolol | 17 | $75 | $4 |
| Citalopram Hbr | 11 | $70 | $6 |
| Triamcinolone Acetonide | 12 | $55 | $5 |
| Benazepril | 11 | $45 | $4 |
| Cephalexin | 12 | $38 | $3 |
2021: 44 drugs
| Trulicity | 17 | $22,965 | $1,351 |
| Symbicort | 15 | $12,475 | $832 |
| Buprenorphine | 36 | $9,629 | $267 |
| Oxycodone | 22 | $2,224 | $101 |
| Albuterol Sulfate Hfa | 21 | $1,532 | $73 |
| Naltrexone | 11 | $1,103 | $100 |
| Omeprazole | 36 | $930 | $26 |
| Gabapentin | 27 | $888 | $33 |
| Levothyroxine | 28 | $798 | $29 |
| Hydrocodone-Acetaminophen | 30 | $752 | $25 |
| Atorvastatin | 55 | $620 | $11 |
| Amitriptyline | 15 | $500 | $33 |
| Tamsulosin | 24 | $422 | $18 |
| Potassium Chloride | 11 | $361 | $33 |
| Losartan | 39 | $361 | $9 |
| Tramadol | 33 | $346 | $10 |
| Montelukast | 23 | $337 | $15 |
| Rosuvastatin | 19 | $330 | $17 |
| Carvedilol | 22 | $321 | $15 |
| Zolpidem | 34 | $310 | $9 |
| Propranolol | 12 | $290 | $24 |
| Fluoxetine | 13 | $289 | $22 |
| Metformin Hcl Er | 15 | $286 | $19 |
| Trazodone | 23 | $283 | $12 |
| Allopurinol | 12 | $269 | $22 |
| Fluticasone Propionate | 13 | $261 | $20 |
| Nitroglycerin | 11 | $256 | $23 |
| Duloxetine | 13 | $248 | $19 |
| Metoprolol | 11 | $219 | $20 |
| Alendronate | 20 | $207 | $10 |
| Lisinopril | 39 | $202 | $5 |
| Furosemide | 18 | $167 | $9 |
| Clonazepam | 15 | $166 | $11 |
| Metformin | 15 | $165 | $11 |
| Lovastatin | 11 | $152 | $14 |
| Lorazepam | 14 | $145 | $10 |
| Fluconazole | 16 | $129 | $8 |
| Sertraline | 12 | $81 | $7 |
| Amlodipine Besylate | 14 | $74 | $5 |
| Meloxicam | 15 | $72 | $5 |
| Prednisone | 17 | $70 | $4 |
| Cephalexin | 12 | $56 | $5 |
| Triamcinolone Acetonide | 14 | $54 | $4 |
| Hydrochlorothiazide | 11 | $36 | $3 |
2020: 36 drugs
| Sublocade | 77 | $135,095 | $1,754 |
| Buprenorphine-Naloxone | 206 | $50,072 | $243 |
| Belbuca | 57 | $39,303 | $690 |
| Suboxone | 53 | $33,234 | $627 |
| Buprenorphine | 73 | $23,488 | $322 |
| Oxycodone | 51 | $20,334 | $399 |
| Vivitrol | 11 | $15,703 | $1,428 |
| Buprenorphine | 106 | $12,712 | $120 |
| Zubsolv | 13 | $9,648 | $742 |
| Butrans | 18 | $9,385 | $521 |
| Acamprosate | 22 | $3,700 | $168 |
| Morphine Sulfate | 12 | $3,091 | $258 |
| Naltrexone | 45 | $2,046 | $45 |
| Duloxetine | 37 | $1,985 | $54 |
| Pregabalin | 34 | $1,753 | $52 |
| Narcan | 13 | $1,698 | $131 |
| Amitriptyline | 47 | $1,539 | $33 |
| Fentanyl | 23 | $1,462 | $64 |
| Bupropion Xl | 61 | $1,091 | $18 |
| Clonazepam | 38 | $780 | $21 |
| Gabapentin | 60 | $645 | $11 |
| Hydrocodone-Acetaminophen | 46 | $461 | $10 |
| Topiramate | 30 | $361 | $12 |
| Sertraline | 29 | $338 | $12 |
| Trazodone | 38 | $319 | $8 |
| Chlordiazepoxide | 60 | $314 | $5 |
| Hydroxyzine | 11 | $303 | $28 |
| Mirtazapine | 19 | $286 | $15 |
| Diazepam | 37 | $170 | $5 |
| Escitalopram | 18 | $168 | $9 |
| Ibuprofen | 16 | $127 | $8 |
| Methadone | 16 | $116 | $7 |
| Ondansetron | 14 | $87 | $6 |
| Lorazepam | 43 | $80 | $2 |
| Quetiapine | 13 | $72 | $6 |
| Omeprazole | 12 | $66 | $6 |
2019: 32 drugs
| Buprenorphine | 121 | $40,865 | $338 |
| Suboxone | 77 | $40,615 | $527 |
| Buprenorphine-Naloxone | 166 | $38,365 | $231 |
| Lyrica | 17 | $12,009 | $706 |
| Zubsolv | 20 | $10,582 | $529 |
| Buprenorphine | 83 | $9,460 | $114 |
| Butrans | 22 | $8,019 | $365 |
| Oxycodone | 60 | $5,555 | $93 |
| Narcan | 22 | $2,847 | $129 |
| Pregabalin | 21 | $2,075 | $99 |
| Gabapentin | 102 | $1,555 | $15 |
| Naltrexone | 35 | $1,510 | $43 |
| Amitriptyline | 61 | $1,222 | $20 |
| Clonazepam | 57 | $1,185 | $21 |
| Duloxetine | 19 | $1,152 | $61 |
| Hydrocodone-Acetaminophen | 40 | $720 | $18 |
| Bupropion Xl | 25 | $670 | $27 |
| Escitalopram | 18 | $425 | $24 |
| Ondansetron Odt | 27 | $330 | $12 |
| Ibuprofen | 12 | $274 | $23 |
| Levothyroxine | 13 | $236 | $18 |
| Methadone | 21 | $230 | $11 |
| Trazodone | 25 | $176 | $7 |
| Allopurinol | 11 | $151 | $14 |
| Chlordiazepoxide | 15 | $137 | $9 |
| Omeprazole | 16 | $119 | $7 |
| Lorazepam | 35 | $109 | $3 |
| Ondansetron | 15 | $104 | $7 |
| Fluoxetine | 13 | $98 | $8 |
| Diazepam | 23 | $82 | $4 |
| Tramadol | 12 | $58 | $5 |
| Alprazolam | 17 | $30 | $2 |
2018: 65 drugs
| Suboxone | 42 | $19,372 | $461 |
| Symbicort | 43 | $16,726 | $389 |
| Lyrica | 26 | $15,326 | $589 |
| Eliquis | 17 | $14,201 | $835 |
| Buprenorphine | 61 | $8,692 | $142 |
| Buprenorphine | 20 | $8,413 | $421 |
| Zubsolv | 33 | $8,036 | $244 |
| Buprenorphine-Naloxone | 26 | $5,347 | $206 |
| Benicar | 11 | $3,360 | $305 |
| Duloxetine | 72 | $2,971 | $41 |
| Gabapentin | 79 | $2,561 | $32 |
| Ventolin Hfa | 28 | $2,112 | $75 |
| Acyclovir | 17 | $2,077 | $122 |
| Hydrocodone-Acetaminophen | 84 | $1,658 | $20 |
| Narcan | 12 | $1,538 | $128 |
| Oxycodone | 20 | $1,213 | $61 |
| Venlafaxine Hcl Er | 20 | $870 | $43 |
| Proair Hfa | 13 | $827 | $64 |
| Bupropion Xl | 21 | $823 | $39 |
| Amitriptyline | 23 | $787 | $34 |
| Levothyroxine | 41 | $751 | $18 |
| Potassium Chloride | 33 | $720 | $22 |
| Fluticasone Propionate | 39 | $649 | $17 |
| Omeprazole | 53 | $644 | $12 |
| Oxycodone-Acetaminophen | 15 | $614 | $41 |
| Metoprolol | 14 | $579 | $41 |
| Escitalopram | 42 | $578 | $14 |
| Synthroid | 12 | $504 | $42 |
| Atorvastatin | 30 | $497 | $17 |
| Tamsulosin | 32 | $462 | $14 |
| Hydromorphone | 11 | $403 | $37 |
| Montelukast | 41 | $380 | $9 |
| Fluoxetine | 25 | $354 | $14 |
| Trazodone | 43 | $351 | $8 |
| Estradiol | 11 | $350 | $32 |
| Losartan | 40 | $333 | $8 |
| Clonazepam | 14 | $311 | $22 |
| Tramadol | 35 | $301 | $9 |
| Nortriptyline | 23 | $288 | $13 |
| Alendronate | 28 | $275 | $10 |
| Donepezil | 12 | $271 | $23 |
| Lisinopril | 33 | $259 | $8 |
| Methadone | 21 | $227 | $11 |
| Hydrochlorothiazide | 30 | $219 | $7 |
| Ropinirole | 11 | $196 | $18 |
| Amlodipine Besylate | 24 | $185 | $8 |
| Simvastatin | 20 | $181 | $9 |
| Ranitidine | 15 | $179 | $12 |
| Triamcinolone Acetonide | 25 | $167 | $7 |
| Fluconazole | 14 | $165 | $12 |
| Glipizide | 22 | $158 | $7 |
| Terazosin | 13 | $139 | $11 |
| Metformin | 27 | $130 | $5 |
| Amoxicillin-Clavulanate Potass | 11 | $124 | $11 |
| Cephalexin | 19 | $119 | $6 |
| Azithromycin | 18 | $113 | $6 |
| Pantoprazole | 19 | $111 | $6 |
| Citalopram Hbr | 14 | $107 | $8 |
| Furosemide | 16 | $92 | $6 |
| Sertraline | 14 | $85 | $6 |
| Prednisone | 16 | $72 | $4 |
| Meloxicam | 14 | $64 | $5 |
| Diazepam | 14 | $61 | $4 |
| Alprazolam | 22 | $58 | $3 |
| Lorazepam | 13 | $47 | $4 |
2017: 51 drugs
| Buprenorphine | 48 | $8,243 | $172 |
| Advair Diskus | 11 | $6,298 | $573 |
| Symbicort | 15 | $5,283 | $352 |
| Chantix | 11 | $3,809 | $346 |
| Duloxetine | 29 | $1,414 | $49 |
| Gabapentin | 52 | $1,308 | $25 |
| Levetiracetam Er | 12 | $1,272 | $106 |
| Ventolin Hfa | 15 | $978 | $65 |
| Venlafaxine Hcl Er | 19 | $966 | $51 |
| Bupropion Xl | 28 | $961 | $34 |
| Proair Hfa | 13 | $861 | $66 |
| Levothyroxine | 30 | $604 | $20 |
| Omeprazole | 53 | $562 | $11 |
| Potassium Chloride | 25 | $502 | $20 |
| Metoprolol | 18 | $455 | $25 |
| Synthroid | 11 | $452 | $41 |
| Hydrocodone-Acetaminophen | 29 | $410 | $14 |
| Atorvastatin | 44 | $396 | $9 |
| Ranitidine | 21 | $380 | $18 |
| Trazodone | 37 | $379 | $10 |
| Montelukast | 35 | $376 | $11 |
| Alendronate | 26 | $292 | $11 |
| Amitriptyline | 13 | $273 | $21 |
| Tamsulosin | 20 | $272 | $14 |
| Metformin | 45 | $255 | $6 |
| Simvastatin | 41 | $248 | $6 |
| Sertraline | 25 | $244 | $10 |
| Mirtazapine | 11 | $243 | $22 |
| Fluticasone Propionate | 19 | $242 | $13 |
| Polyethylene Glycol 3350 | 15 | $242 | $16 |
| Losartan | 29 | $206 | $7 |
| Escitalopram | 25 | $198 | $8 |
| Warfarin | 14 | $189 | $14 |
| Lisinopril | 28 | $173 | $6 |
| Prednisone | 28 | $170 | $6 |
| Furosemide | 41 | $149 | $4 |
| Allopurinol | 12 | $144 | $12 |
| Quetiapine | 15 | $120 | $8 |
| Topiramate | 15 | $112 | $7 |
| Ciprofloxacin | 13 | $111 | $9 |
| Azithromycin | 22 | $105 | $5 |
| Glipizide | 31 | $97 | $3 |
| Amlodipine Besylate | 26 | $97 | $4 |
| Lorazepam | 15 | $94 | $6 |
| Hydrochlorothiazide | 18 | $85 | $5 |
| Pantoprazole | 15 | $78 | $5 |
| Triamcinolone Acetonide | 15 | $72 | $5 |
| Tramadol | 14 | $59 | $4 |
| Triamterene-Hydrochlorothiazid | 19 | $58 | $3 |
| Metformin Hcl Er | 11 | $47 | $4 |
| Alprazolam | 12 | $38 | $3 |
2016: 23 drugs
| Symbicort | 13 | $4,229 | $325 |
| Hydrocodone-Acetaminophen | 42 | $1,097 | $26 |
| Duloxetine | 15 | $917 | $61 |
| Mirtazapine | 22 | $882 | $40 |
| Ventolin Hfa | 13 | $776 | $60 |
| Bupropion | 13 | $555 | $43 |
| Gabapentin | 29 | $530 | $18 |
| Escitalopram | 23 | $528 | $23 |
| Fluoxetine | 31 | $416 | $13 |
| Fluticasone Propionate | 22 | $391 | $18 |
| Fluconazole | 11 | $253 | $23 |
| Bupropion Xl | 13 | $220 | $17 |
| Levothyroxine | 11 | $204 | $19 |
| Lisinopril | 35 | $179 | $5 |
| Omeprazole | 21 | $174 | $8 |
| Ibuprofen | 18 | $166 | $9 |
| Trazodone | 13 | $153 | $12 |
| Metformin | 22 | $153 | $7 |
| Diltiazem 24hr Er | 11 | $128 | $12 |
| Losartan | 18 | $123 | $7 |
| Lorazepam | 24 | $121 | $5 |
| Pantoprazole | 12 | $103 | $9 |
| Ranitidine | 13 | $72 | $6 |
2015: 4 drugs
| Hydrocodone-Acetaminophen | 46 | $955 | $21 |
| Pantoprazole | 20 | $180 | $9 |
| Gabapentin | 15 | $174 | $12 |
| Lisinopril | 13 | $70 | $5 |
Money from drug and device companies
$92 in 2023
| 2023 | 1 | 1 | None | $92 |
| 2020 | 6 | 28 | None | $432 |
| 2019 | 6 | 35 | None | $490 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Gilead Sciences | Epclusa | $92 | 1 payment
|
See the published payment
| Gilead Sciences | Meals · 2023-02-08 | Epclusa | $92 |
See earlier years (2020, 2019)
2020: $432
| Gilead Sciences | None | $261 | 19 payments
|
| Alkermes | Vivitrol | $73 | 4 payments
|
| Shionogi | Mulpleta | $34 | 1 payment
|
| Biodelivery Sciences International | Belbuca | $26 | 2 payments
|
| Indivior | Sublocade | $21 | 1 payment
|
| Orexo US | Zubsolv | $18 | 1 payment
|
2019: $490
| Gilead Sciences | Epclusa | $325 | 26 payments
|
| Alkermes | Vivitrol | $44 | 2 payments
|
| Indivior | Sublocade | $44 | 2 payments
|
| GlaxoSmithKline | Shingrix | $32 | 2 payments
|
| BioDelivery Sciences International | Bunavail 2.1 Mg 30-Count Box | $24 | 2 payments
|
| Otsuka America Pharmaceutical | Abilify Maintena | $22 | 1 payment
|
Professional record
- NPI
- 1487097929
- Licence
- CA A132204California A132204: Current · expires 2027-11-30
- Trained
- University of Utah School of Medicine, 2013
- Group
- Sutter Valley Medical Foundation · Sutter Bay Medical Foundation · Marshall Medical Center
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207QA0401X (207QA0401X); Family medicine (207Q00000X)
- Mailing address
- Po Box 255228, Sacramento, CA, 95865
- NPI first listed
- 2013-04-15
- NPI last updated
- 2021-01-14
- NPI record certified
- 2021-01-14
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 12125 Shale Ridge Ln, Auburn, CA, 95602 · 12183 Locksley Ln Ste 101, Auburn, CA, 95602 · 159 Brentwood Dr, Grass Valley, CA, 95945 · 180 Sierra College Dr, Grass Valley, CA, 95945 · 1530 3rd St Ste 106, Lincoln, CA, 95648 · 145 Bost Ave, Nevada City, CA, 95959 · 1045 Marshall Way, Placerville, CA, 95667 · 4341b Golden Center Dr, Placerville, CA, 95667 · 730 Sunrise Ave, Roseville, CA, 95661